Literature DB >> 10653064

Fulfillment of diagnostic criteria in Kawasaki disease.

J Stapp1, G S Marshall.   

Abstract

BACKGROUND: The diagnosis of Kawasaki disease (KD) is made by fulfillment of clinical criteria. The dramatic effectiveness of intravenous immune globulin in this disease might lead to treatment of cases that do not meet those criteria.
METHODS: A retrospective review was conducted of all cases of KD treated at Kosair Children's Hospital between January 1993 and July 1997.
RESULTS: Fifty-six patients were identified. Demographic features were similar to reports from other regions of the country. Forty-eight children fulfilled criteria for typical or atypical KD and 8 (14%) did not. The latter children were not distinguished from those meeting criteria by standard laboratory test results. Echocardiographic abnormalities were found in 17 cases, including 3 with coronary artery aneurysms, but all abnormalities eventually resolved.
CONCLUSIONS: The treatment of 14% of patients despite incomplete diagnostic criteria illustrates the tendency to be liberal in treatment decisions regarding KD. Whether this proportion of patients has a forme fruste of the illness that warrants treatment will await definitive biological markers for the syndrome.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10653064

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  3 in total

1.  Atypical Kawasaki disease with remarkable paucity of signs and symptoms.

Authors:  Rajoo Thapa; Subroto Chakrabartty
Journal:  Rheumatol Int       Date:  2009-04-21       Impact factor: 2.631

2.  Incomplete, atypical kawasaki disease or evolving systemic juvenile idiopathic arthritis: a case report.

Authors:  Shakeel Shaikh; Sidra Ishaque; Taimur Saleem
Journal:  Cases J       Date:  2009-08-06

3.  Atypical Kawasaki Disease in a 4 Years Old Child with Mumps.

Authors:  Prakash Banjade; Kiran Subedi
Journal:  JNMA J Nepal Med Assoc       Date:  2018 Jul-Aug       Impact factor: 0.406

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.